Skip to content
  • Services
    • Biodistribution
    • Molecular Analysis
    • Clinical Assay Development
    • miRNA Analysis
    • Exosome Isolation
  • Platforms
    • Olink® Proteomics
    • ELLA® Simplex ELISA
  • LDT/Diagnostics
    • HepatoTrack™
  • Resources
    • Posters and Publications​
  • About
    • Who We Are
    • Management
    • News
    • Events
  • Contact Us
  • Services
    • Biodistribution
    • Clinical Assay Development
    • Molecular Analysis
    • miRNA Analysis
    • Exosome Isolation
  • Platforms
    • Olink® Proteomics
    • ELLA® Simplex ELISA
  • LDT/Diagnostics
    • HepatoTrack™
  • Resources
    • Posters and Publications​
  • About
    • Who We Are
    • Management
    • News
    • Events
  • Contact Us
Skip to main content

LuminoDx Inc

https://pancan.org/news/first-ras-inhibitor-extends-survival-in-previously-treated-metastatic-pancreatic-adenocarcinoma-what-you-need-to-know

Back to list
Older LuminoDx AACR 2026 Announcement
Linkedin

Useful links

  • Olink analysis
  • Exosome Isolation
  • Clinical Assay Development
  • Acute allograft rejection Monitoring
  • About Us
  • Contact Us

Contact info

  • 7438 Trade St, San Diego, CA 92121
  • (858) 333-7527
  • info@luminodx.com
  • Office Hours: 8AM- 5PM
  • Monday - Friday

© Copyright ©2025 LuminoDx Inc All Rights Reserved Copyright

  • Privacy policy